Takeda Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Takeda Pharmaceuticals USA Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013912
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, pioglitazone, pioglitazone and metformin HCl, azilsartan medoxomil, alogliptin, peginesatide, lansoprazole, colchicine, USP, dexlansoprazole, ramelteon and febuxostat. It offers products in therapeutic areas including cardiovascular disease, central nervous system disorders, bone and joint disorders, gastroenterology, gynecology disorders, kidney disorders and other infectious diseases. TPUSA conducts research and development activities to develop new drugs. The company markets its products through its distributors in the US. TPUSA is headquartered in Deerfield, Illinois, the US.

Takeda Pharmaceuticals USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 10
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 11
Affymax Enters Into Co-Promotion Agreement With Takeda For Peginesatide 12
Teijin Pharma Enters Into Co-Marketing Agreement With Takeda Pharma North America For TMX-67 13
Asset Transactions 14
Caraco Pharma Completes Acquisition Of Non-Colcrys Business Of URL Pharma From Takeda Pharma For US$65 Million 14
Takeda Pharmaceuticals USA Inc – Key Competitors 15
Takeda Pharmaceuticals USA Inc – Key Employees 16
Takeda Pharmaceuticals USA Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Oct 06, 2017: Takeda Donates $100,000 to Local, Regional Charities as Part of Company’s Takeda Cares Day Event 18
Other Significant Developments 19
Sep 07, 2016: Takeda Launches Wearable Digital Technology Pilot Program to Support Patients and Healthcare Providers with Inflammatory Bowel Disease Management 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Key Facts 2
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Takeda Pharmaceuticals USA Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Takeda Pharmaceuticals USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 10
Prasco Lab Enters into Co-Marketing Agreement with Takeda Pharma 11
Affymax Enters Into Co-Promotion Agreement With Takeda For Peginesatide 12
Teijin Pharma Enters Into Co-Marketing Agreement With Takeda Pharma North America For TMX-67 13
Caraco Pharma Completes Acquisition Of Non-Colcrys Business Of URL Pharma From Takeda Pharma For US$65 Million 14
Takeda Pharmaceuticals USA Inc, Key Competitors 15
Takeda Pharmaceuticals USA Inc, Key Employees 16

★海外企業調査レポート[Takeda Pharmaceuticals USA Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Edge Therapeutics Inc (EDGE):製薬・医療:M&Aディール及び事業提携情報
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neuro …
  • Immunicum AB (IMMU):企業の財務・戦略的SWOT分析
    Summary Immunicum AB (Immunicum) develops allogeneic and off-the-shelf cell-based therapies for treating solid tumors. The company’s lead product candidate ilixadencel, an off the cell cancer immune primer is used for the treatment of renal cell carcinoma, gastrointestinal stromal tumors, head and n …
  • Snowy Hydro Ltd:企業の戦略的SWOT分析
    Snowy Hydro Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Mednax Inc (MD):製薬・医療:M&Aディール及び事業提携情報
    Summary Mednax Inc (Mednax) is a national medical group company, which operates a network of physician service providers. The company offers a wide range of neonatal, anesthesia, maternal-fetal, pediatric physician and subspecialty services. Its network includes other pediatric subspecialists compri …
  • ProterixBio Inc-医療機器分野:企業M&A・提携分析
    Summary ProterixBio Inc (ProterixBio), formerly BioScale Inc is a medical device company that manufactures and markets the ViBE platform products. The company offers ViBE platform, acoustic assays; ViBE software and custom assays. Its ViBE platform enables non-optical detection and sensitive quantit …
  • Newhaven Hotels Limited:企業の戦略・SWOT・財務分析
    Newhaven Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Newhaven Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • LSIS Co Ltd (010120):電力:M&Aディール及び事業提携情報
    Summary LSIS Co Ltd (LSIS) is a provider of power and automation solutions. It manufactures, sells and maintains electronic instruments, copper pipes and automatic machinery. The company provides smart transmission, smart distribution, and smart industrial automation solutions. Under contractual agr …
  • Olam International Ltd:戦略・SWOT・企業財務分析
    Olam International Ltd - Strategy, SWOT and Corporate Finance Report Summary Olam International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Arise AB (ARISE):電力:M&Aディール及び事業提携情報
    Summary Arise AB (Arise) is an integrated onshore wind company. It involves in project development and sale of electricity generation through its onshore wind turbines. The company manages exploration, construction, sale, long-term management and financing of its own and third party wind farms. Aris …
  • Uranium Energy Corp:企業の戦略・SWOT・財務分析
    Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • RMB Holdings Ltd. (RMH):企業の財務・戦略的SWOT分析
    RMB Holdings Ltd. (RMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Hydro One Ltd (H):電力:M&Aディール及び事業提携情報
    Summary Hydro One Ltd (Hydro One) is a utility holding company that conducts electricity transmission and distribution in Ontario through its subsidiaries. It also undertakes telecommunications business and certain corporate activities. The company serves residential, commercial and industrial custo …
  • Novartis India Ltd (500672):企業の財務・戦略的SWOT分析
    Summary Novartis India Ltd (Novartis), a subsidiary of Novartis AG, is a healthcare company that offers pharmaceuticals, generic medicine and eye care products. The company’s pharmaceutical division develops drugs in the therapeutic areas of bone and pain, calcium portfolio, gynecology, oncology and …
  • QEP Resources, Inc.:企業の戦略・SWOT・財務分析
    QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Crestwood Midstream Partners LP:企業のM&A・事業提携・投資動向
    Crestwood Midstream Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Crestwood Midstream Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析
    Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Known as Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary p …
  • Sinolink Worldwide Holdings Ltd:企業の戦略・SWOT・財務情報
    Sinolink Worldwide Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Sinolink Worldwide Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Fortis Inc.:企業の戦略・SWOT・財務情報
    Fortis Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortis Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • DEA Deutsche Erdoel AG:石油・ガス:M&Aディール及び事業提携情報
    Summary DEA Deutsche Erdoel AG (DEA), a subsidiary of Letterone Holdings S.A., is an upstream company that explores for and produces oil and natural gas. The company operates onshore and offshore projects in Egyptian Nile delta, Mittelplate Island and Norwegian coast line and other regions. It also …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆